Phreesia Debt to Equity Ratio 2019-2025 | PHR
Current and historical debt to equity ratio values for Phreesia (PHR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Phreesia debt/equity for the three months ending April 30, 2025 was 0.02.
| Phreesia Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-04-30 | $0.12B | $0.28B | 0.42 |
| 2025-01-31 | $0.12B | $0.27B | 0.47 |
| 2024-10-31 | $0.12B | $0.26B | 0.48 |
| 2024-07-31 | $0.11B | $0.25B | 0.44 |
| 2024-04-30 | $0.12B | $0.25B | 0.47 |
| 2024-01-31 | $0.12B | $0.25B | 0.47 |
| 2023-10-31 | $0.11B | $0.27B | 0.42 |
| 2023-07-31 | $0.09B | $0.25B | 0.38 |
| 2023-04-30 | $0.09B | $0.26B | 0.34 |
| 2023-01-31 | $0.08B | $0.29B | 0.29 |
| 2022-10-31 | $0.08B | $0.32B | 0.24 |
| 2022-07-31 | $0.08B | $0.35B | 0.22 |
| 2022-04-30 | $0.08B | $0.38B | 0.20 |
| 2022-01-31 | $0.08B | $0.42B | 0.19 |
| 2021-10-31 | $0.07B | $0.46B | 0.16 |
| 2021-07-31 | $0.07B | $0.49B | 0.13 |
| 2021-04-30 | $0.06B | $0.50B | 0.12 |
| 2021-01-31 | $0.06B | $0.26B | 0.24 |
| 2020-10-31 | $0.07B | $0.27B | 0.25 |
| 2020-07-31 | $0.06B | $0.10B | 0.64 |
| 2020-04-30 | $0.06B | $0.10B | 0.61 |
| 2020-01-31 | $0.06B | $0.10B | 0.56 |
| 2019-10-31 | $0.05B | $0.10B | 0.52 |
| 2019-07-31 | $0.06B | $0.10B | 0.59 |
| 2019-04-30 | $0.00B | $0.00B | 0.00 |
| 2019-01-31 | $0.00B | 0.00 | |
| 2018-10-31 | $0.00B | $0.00B | 0.00 |
| 2018-07-31 | $0.00B | $0.00B | 0.00 |
| 2018-01-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.560B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.768B | 58.23 |
| Hims & Hers Health (HIMS) | United States | $14.374B | 149.35 |
| Tempus AI (TEM) | United States | $11.826B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
| Hinge Health (HNGE) | United States | $3.282B | 0.00 |
| Privia Health (PRVA) | United States | $2.664B | 182.08 |
| Enovis (ENOV) | United States | $1.720B | 9.59 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Schrodinger (SDGR) | United States | $1.501B | 0.00 |
| Azenta (AZTA) | United States | $1.357B | 63.06 |
| 10x Genomics (TXG) | United States | $1.331B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Claritev (CTEV) | United States | $0.657B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.448B | 134.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| CareCloud (CCLD) | United States | $0.106B | 4.03 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |